This is a past event. Registration is closed. View other Stanford events.
Feng CHEN
Professor, Dean at Nanjing Medical University
Jie CHEN
Distinguished Scientist at Merck Research Laboratories- Welcome address
- Session 6: Evaluating and Monitoring Safety of Drug and Other Medical Products
- Closing Remarks
- A Half-Day Short Course: Statistical Methods for Medical Product Safety Evaluation
More than 24 years of experience in biopharmaceutical research and development with research interest in the areas of innovative trial design, data analysis, Bayesian analysis, multiregional clinical trials, data mining, machine learning and medical product safety evaluation; most recently focusing on sequential testing and monitoring of safety signals; over 30 publications in peer reviewed journals (and book chapters)
YC
YC
JC
JF
TG
LH
Liyun HE
Chinese Academy of Chinese Medicine SciencesYH
Yi HUANG
University of Maryland Baltimore CountyJH
Joseph Heyse
Scientific Assistant Vice President at Merck Research Laboratories- Session 5: Statistical Challenges Evaluating the Safety of Vaccines
- A Half-Day Short Course: Statistical Methods for Medical Product Safety Evaluation
A Scientific Assistant Vice President at Merck Research Laboratories, Fellow of the ASA and AAAS, and founding editor of Statistics in Biopharmaceutical Research. He has more than 40 years of experience in pharmaceutical R&D with research interest in safety evaluation and health economics and has more than 70 publications in peer reviewed journals. He is an editor of Statistical Methods in Medical Research.
Tse Leung LAI
Ray Lyman Wilbur Professor of Statistics and, by courtesy, of Health Research and Policy in the School of Medicine at Stanford UniversityHL
Hailong LI
Peking UniversityQL
ZL
Zhengqing LI
Merck Research Laboratories
Ying LU
Professor of Biomedical Data Science；Professor (By courtesy), Radiology - Rad/Molecular Imaging Program; Professor (By courtesy), Health Research & Policy at Stanford University
Bruce Ling
Professor, Principle InvestigatorFollowing his PhD under Academy member Dr. Michael Grunstein from UCLA, Dr. Ling did a post-doc in molecular immunology under Dr. Alan Krensky at Stanford Medicine and simultaneously trained in computer science. Dr. Ling’s investigative interests are in translation medicine that bridge molecular biology and biomedical computation. Dr. Ling brings a great depth of experience and demonstrated success in using his computational skills to create both platforms and products with obvious translational utility. During his tenure at Stanford, Dr. Ling has been instrumental in creating the computational infrastructure to support diagnostic biomarker discovery and more recently in providing mechanism of disease insight. Dr. Ling has established a number of fertile collaborations both within the Stanford community as well as with other leading scientists in academia and industry.
HS
LS
Ling SU
Shenyang Pharmaceutical University
Lu TIAN
Associate Professor of Biomedical Data Science; Associate Professor, by courtesy, of Statistics at Stanford UniversityJW
JX
Jielai XIA
The Fourth Military Medical UniversityLX
YX
JY
YY
Yu YANG
Peking UniversitySZ
Siyan ZHAN
Peking University School of Public HealthXZ
Hao ZOU
Tsinghua University; Stanford University
James ZOU
Assistant Professor of Biomedical Data Science and, by courtesy, of Computer Science and Electrical Engeneering at Stanford UniversityChina speakers